Russell Investments Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $143M | Buy |
1,646,202
+8,124
| +0.5% | +$778K | 0.15% | 133 |
|
|
2025
Q4 | $157M | Buy |
1,638,078
+83,573
| +5% | +$8.12M | 0.17% | 112 |
|
|
2025
Q3 | $148M | Sell |
1,554,505
-220,919
| -12% | -$20.3M | 0.17% | 113 |
|
|
2025
Q2 | $155M | Buy |
1,775,424
+13,799
| +0.8% | +$1.17M | 0.2% | 91 |
|
|
2025
Q1 | $158M | Buy |
1,761,625
+120,623
| +7% | +$10.8M | 0.22% | 84 |
|
|
2024
Q4 | $131M | Buy |
1,641,002
+84,294
| +5% | +$7.3M | 0.18% | 107 |
|
|
2024
Q3 | $140M | Sell |
1,556,708
-742,176
| -32% | -$62.4M | 0.2% | 91 |
|
|
2024
Q2 | $181M | Sell |
2,298,884
-33,040
| -1% | -$2.71M | 0.29% | 58 |
|
|
2024
Q1 | $203M | Buy |
2,331,924
+159,514
| +7% | +$13.6M | 0.32% | 47 |
|
|
2023
Q4 | $179M | Buy |
2,172,410
+175,788
| +9% | +$13.4M | 0.32% | 52 |
|
|
2023
Q3 | $157M | Buy |
1,996,622
+82,322
| +4% | +$6.89M | 0.31% | 53 |
|
|
2023
Q2 | $168M | Buy |
1,914,300
+20,964
| +1% | +$1.8M | 0.32% | 48 |
|
|
2023
Q1 | $152M | Sell |
1,893,336
-9,629
| -0.5% | -$785K | 0.3% | 54 |
|
|
2022
Q4 | $148M | Buy |
1,902,965
+106,462
| +6% | +$8.63M | 0.3% | 56 |
|
|
2022
Q3 | $146M | Sell |
1,796,503
-555,845
| -24% | -$50M | 0.32% | 47 |
|
|
2022
Q2 | $211M | Buy |
2,352,348
+208,712
| +10% | +$21.1M | 0.43% | 30 |
|
|
2022
Q1 | $238M | Buy |
2,143,636
+723,230
| +51% | +$76.4M | 0.41% | 29 |
|
|
2021
Q4 | $147M | Sell |
1,420,406
-56,273
| -4% | -$6.52M | 0.23% | 73 |
|
|
2021
Q3 | $185M | Sell |
1,476,679
-87,018
| -6% | -$11.3M | 0.31% | 50 |
|
|
2021
Q2 | $194M | Sell |
1,563,697
-6,656
| -0.4% | -$836K | 0.32% | 43 |
|
|
2021
Q1 | $186M | Sell |
1,570,353
-15,164
| -1% | -$1.78M | 0.33% | 43 |
|
|
2020
Q4 | $185M | Sell |
1,585,517
-128,322
| -7% | -$14.1M | 0.37% | 38 |
|
|
2020
Q3 | $177M | Sell |
1,713,839
-138,370
| -7% | -$13.9M | 0.38% | 31 |
|
|
2020
Q2 | $169M | Sell |
1,852,209
-265,078
| -13% | -$25.4M | 0.38% | 34 |
|
|
2020
Q1 | $193M | Sell |
2,117,287
-177,342
| -8% | -$18.9M | 0.5% | 27 |
|
|
2019
Q4 | $260M | Buy |
2,294,629
+153,971
| +7% | +$16.9M | 0.48% | 23 |
|
|
2019
Q3 | $231M | Sell |
2,140,658
-38,007
| -2% | -$3.97M | 0.45% | 28 |
|
|
2019
Q2 | $212M | Sell |
2,178,665
-292,981
| -12% | -$26.7M | 0.4% | 33 |
|
|
2019
Q1 | $224M | Buy |
2,471,646
+214,178
| +9% | +$19.2M | 0.41% | 32 |
|
|
2018
Q4 | $204M | Buy |
2,257,468
+139,456
| +7% | +$13M | 0.46% | 27 |
|
|
2018
Q3 | $208M | Buy |
2,118,012
+55,147
| +3% | +$5.1M | 0.39% | 34 |
|
|
2018
Q2 | $177M | Sell |
2,062,865
-495,831
| -19% | -$41.4M | 0.37% | 40 |
|
|
2018
Q1 | $204M | Sell |
2,558,696
-204,054
| -7% | -$16.8M | 0.35% | 41 |
|
|
2017
Q4 | $225M | Sell |
2,762,750
-536,720
| -16% | -$43M | 0.38% | 35 |
|
|
2017
Q3 | $257M | Sell |
3,299,470
-42,804
| -1% | -$3.55M | 0.44% | 28 |
|
|
2017
Q2 | $297M | Buy |
3,342,274
+657,700
| +24% | +$55.5M | 0.53% | 23 |
|
|
2017
Q1 | $216M | Sell |
2,684,574
-312,200
| -10% | -$24.4M | 0.4% | 33 |
|
|
2016
Q4 | $214M | Buy |
+2,996,774
| New | +$235M | 0.42% | 30 |
|
Other funds holding MDT
VCM
VPM
Russell Investments Group's MDT Position: Q1 2026 in Review
Russell Investments Group increased its Medtronic (MDT) stake by 0.5% in Q1 2026, buying an estimated $778K and bringing the position to 1,646,202 shares worth $143M. The position accounts for 0.15% of the portfolio, ranked #133.
Russell Investments Group first reported a position in MDT in Q4 2016 and has held it in 38 quarters since. The position peaked at $297M in Q2 2017. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Russell Investments Group held 1,646,202 shares of Medtronic worth $143M as of Q1 2026.
- Russell Investments Group bought 8,124 Medtronic shares in Q1 2026, an estimated $778K.
- Medtronic made up 0.15% of Russell Investments Group's portfolio in Q1 2026, its #133 holding.
- Russell Investments Group first reported a position in Medtronic in Q4 2016 and has held it in 38 quarters since.
- Russell Investments Group's Medtronic position peaked at $297M in Q2 2017.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.